Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19038367 | INTRANASAL AND OLFACTORY DELIVERY DEVICES AND METHODS OF USE | January 2025 | May 2025 | Allow | 3 | 1 | 0 | No | No |
| 19028589 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | June 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19028358 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | May 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 19028896 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | June 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19002468 | APPLICATOR FOR A MICRONEEDLE ARRAY PATCH DELIVERY SYSTEM | December 2024 | June 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 18764716 | MULTI-FUNCTION ANALYTE MONITOR DEVICE AND METHODS OF USE | July 2024 | April 2025 | Allow | 10 | 2 | 0 | Yes | No |
| 18239646 | PRESSURE ACTUATED FLOW CONTROL DEVICE FOR GRAVITY IV SETS | August 2023 | March 2025 | Allow | 19 | 1 | 0 | Yes | No |
| 18224395 | METHOD AND DEVICE FOR ENHANCED COMPOSITION DELIVERY | July 2023 | April 2024 | Allow | 9 | 1 | 0 | No | No |
| 18325985 | ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAME | May 2023 | January 2024 | Allow | 8 | 1 | 0 | Yes | No |
| 18199747 | SYRINGE PUMP | May 2023 | June 2025 | Allow | 25 | 1 | 0 | No | No |
| 18108449 | INTEGRATED VASCULAR DELIVERY SYSTEM | February 2023 | July 2025 | Allow | 29 | 1 | 0 | Yes | No |
| 17956420 | INJECTOR DEVICE | September 2022 | September 2024 | Allow | 24 | 0 | 0 | No | No |
| 17935306 | DEVICE FOR MONITORING AND TREATING BRADYARRHYTHMIA | September 2022 | February 2023 | Allow | 5 | 1 | 0 | Yes | No |
| 17896452 | AUTO-INJECTOR WITH ACTIVE AGENT CONTAINER LATCHING | August 2022 | December 2024 | Allow | 28 | 1 | 0 | Yes | No |
| 17820385 | ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAME | August 2022 | June 2023 | Allow | 10 | 1 | 0 | Yes | No |
| 17883302 | SYSTEMS AND METHODS FOR CROSS-LINKING TREATMENTS OF AN EYE | August 2022 | June 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17868600 | SUBCUTANEOUS ACCESS HUB WITH MULTIPLE CANNULA PORTS | July 2022 | May 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17867224 | Priming System for Infusion Devices | July 2022 | April 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 17758903 | A MEDICAL DEVICE | July 2022 | April 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 17855857 | Delivery System And Method For Delivering Material To A Target Site During A Medical Procedure | July 2022 | June 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17807736 | EXTERNAL CATHETER STABILIZER | June 2022 | April 2025 | Allow | 34 | 1 | 1 | No | No |
| 17740153 | MONITORING UPSTREAM FLOW CHARACTERISTICS FOR A PUMP | May 2022 | March 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17661387 | Guidewire Retraction Device | April 2022 | April 2023 | Allow | 12 | 2 | 0 | Yes | No |
| 17719418 | SYRINGE WITH FLEXIBLE RESERVOIR AND METHOD OF USE | April 2022 | August 2023 | Abandon | 16 | 2 | 0 | No | No |
| 17720175 | SYSTEMS AND METHODS TO AUTOMATICALLY ADMINISTER A PSYCHOACTIVE SUBSTANCE TO AN AIRWAY OF A USER BASED ON A DETECTED EVENT OR CONDITION | April 2022 | January 2023 | Allow | 9 | 2 | 0 | Yes | No |
| 17715891 | PRESSURE-REGULATING CONNECTOR FOR INFUSION | April 2022 | February 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17715047 | CONNECTOR ADAPTED TO ATTACH AN IRRIGATION CATHETER TO TUBING OF AN ANAL OR STOMAL IRRIGATION SYSTEM | April 2022 | April 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17706708 | IV FLOW REGULATOR | March 2022 | March 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17707863 | RADIOACTIVE CONDUIT AND METHOD FOR IN VIVO TREATMENT OF TUMORS | March 2022 | December 2023 | Allow | 21 | 2 | 1 | Yes | No |
| 17656531 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | March 2022 | May 2025 | Allow | 38 | 1 | 1 | Yes | No |
| 17655900 | DEVICE AND METHOD FOR MONITORING AND TREATING ADVANCED BRADYCARDIA | March 2022 | June 2022 | Allow | 3 | 1 | 0 | Yes | No |
| 17701439 | LAMPREY LOCK DEVICE | March 2022 | September 2022 | Allow | 6 | 1 | 0 | Yes | No |
| 17685389 | NASAL ASPIRATOR CAPABLE OF EFFECTIVELY PREVENTING BACKFLOW AND CONTROL METHOD THEREOF | March 2022 | August 2022 | Allow | 5 | 1 | 0 | No | No |
| 17639641 | PATIENT LINE AIR DETECTION AND REUSE PREVENTION | March 2022 | January 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17669918 | Adjustable Medium Diverter | February 2022 | May 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17590175 | INJECTOR AND METHOD OF ASSEMBLY | February 2022 | February 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17558577 | METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCER | December 2021 | October 2022 | Allow | 10 | 2 | 0 | Yes | No |
| 17549974 | Systems and Methods for Guidewire Retraction | December 2021 | May 2022 | Allow | 5 | 1 | 0 | Yes | No |
| 17518044 | ELECTROCHEMICAL PUMP UNIT OF MESH COMBINED ELECTRODE | November 2021 | February 2025 | Allow | 40 | 1 | 0 | Yes | No |
| 17498525 | EVENT CAPTURE DEVICE FOR MEDICATION DELIVERY INSTRUMENTS | October 2021 | January 2025 | Allow | 39 | 1 | 0 | Yes | No |
| 17493118 | VOLUME MONITORING SYSTEMS | October 2021 | March 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17489620 | SUBARACHNOID FLUID MANAGEMENT METHOD AND SYSTEM WITH VARYING RATES | September 2021 | February 2025 | Allow | 41 | 1 | 1 | Yes | No |
| 17489625 | SUBARACHNOID FLUID MANAGEMENT METHOD AND SYSTEM | September 2021 | February 2025 | Allow | 41 | 1 | 1 | Yes | No |
| 17448618 | SURGICAL HUMIDIFIER CONTROL | September 2021 | January 2025 | Allow | 40 | 1 | 0 | Yes | No |
| 17476426 | MEDICAL DEVICE AND METHOD FOR LIMITING THE USE OF THE MEDICAL DEVICE | September 2021 | June 2022 | Allow | 9 | 2 | 0 | Yes | No |
| 17462130 | DRUG DELIVERY VIA MECHANICAL VIBRATION BALLOON | August 2021 | September 2024 | Allow | 37 | 1 | 0 | Yes | No |
| 17406760 | MEDIUM INJECTION DIVERSION AND MEASUREMENT | August 2021 | January 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17405656 | INTRAVENOUS CATHETER DEVICE WITH INTEGRATED EXTENSION TUBE | August 2021 | September 2024 | Allow | 37 | 1 | 0 | Yes | No |
| 17398370 | SYSTEMS AND METHODS FOR CONTROLLED DELIVERY OF ANALGESIC AND HYPNOTIC AGENTS | August 2021 | April 2025 | Allow | 44 | 1 | 0 | Yes | No |
| 17393187 | SUCTION DEVICE FOR SUCKING OBSTRUCTION IN RESPIRATORY TRACT AND USE METHOD THEREFOR | August 2021 | March 2023 | Allow | 19 | 3 | 0 | Yes | No |
| 17355061 | Medicament Delivery Device with Rotator Retaining the Plunger Rod | June 2021 | September 2024 | Allow | 38 | 1 | 0 | No | No |
| 17350883 | INJECTOR AND METHOD OF ASSEMBLY | June 2021 | November 2021 | Allow | 5 | 0 | 0 | Yes | No |
| 17335996 | Intravenous Fluid Delivery System and Apparatus | June 2021 | August 2023 | Allow | 27 | 5 | 1 | Yes | No |
| 17244898 | RETRACTABLE NEEDLE CATHETER DELIVERY APPARATUS | April 2021 | October 2021 | Allow | 6 | 1 | 0 | Yes | No |
| 17237070 | A NOVEL PHOTOTHERAPY FACE MASK | April 2021 | December 2024 | Allow | 44 | 4 | 0 | Yes | No |
| 17282503 | DEFORMABLE CARTRIDGE FOR INJECTION DEVICE | April 2021 | October 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17213317 | DEVICE FOR ASSISTING ACCESS TO A SUBCUTANEOUS PORT | March 2021 | April 2025 | Abandon | 49 | 2 | 0 | No | No |
| 17211741 | CATHETER CLEARANCE DEVICE AND METHOD OF USE | March 2021 | March 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17277581 | AUTOINJECTOR | March 2021 | August 2024 | Allow | 41 | 1 | 0 | Yes | No |
| 17274268 | SYRINGE COLLAR AND FRAME | March 2021 | November 2024 | Abandon | 44 | 1 | 1 | No | No |
| 17191127 | AUTO-INJECTOR WITH ACTIVE AGENT CONTAINER LATCHING | March 2021 | April 2022 | Allow | 14 | 3 | 0 | Yes | No |
| 17272701 | Medical Instrument for the Targeted Introduction of a Substance into a Body Cavity, and Tool Therefor | March 2021 | September 2021 | Allow | 6 | 1 | 0 | No | No |
| 17248822 | VACUUM POWERED SALINE INJECTION SYSTEM | February 2021 | July 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17166391 | CARTRIDGE PORTION OF TRANSDERMAL DRUG DELIVERY APPARATUS AND METHODS | February 2021 | July 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17161107 | SAFETY NEEDLE SYSTEM OPERABLE WITH A MEDICAL DEVICE | January 2021 | April 2024 | Allow | 38 | 1 | 0 | Yes | No |
| 17146948 | MEDICAL DEVICE AND METHOD FOR LIMITING THE USE OF THE MEDICAL DEVICE | January 2021 | February 2024 | Allow | 37 | 1 | 0 | No | No |
| 17141098 | Catheter Clearance Device and Method of Use | January 2021 | September 2024 | Allow | 44 | 3 | 1 | Yes | No |
| 17257418 | CANNULA SYSTEM AND USE THEREOF | December 2020 | October 2024 | Abandon | 46 | 1 | 1 | No | No |
| 17105056 | ELECTRICALLY RESPONSIVE, NANOPATTERNED SURFACE FOR TRIGGERED INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | November 2020 | October 2024 | Abandon | 46 | 1 | 1 | No | No |
| 17105117 | AUTOINJECTOR WITH A SIGNALING DEVICE | November 2020 | November 2023 | Allow | 36 | 1 | 0 | No | No |
| 17095980 | PHOTODYNAMIC THERAPY ABLATION DEVICE | November 2020 | March 2025 | Abandon | 52 | 2 | 1 | Yes | No |
| 17075146 | RESERVOIR FOR COLLECTION AND REUSE OF DIVERTED MEDIUM | October 2020 | February 2024 | Allow | 39 | 1 | 0 | No | No |
| 17065475 | PROTECTIVE RELEASE SHEET FOR MICRONEEDLE PATCH | October 2020 | January 2024 | Allow | 40 | 2 | 0 | No | No |
| 17028339 | APPARATUS FOR PREVENTING BACKFLOW | September 2020 | May 2024 | Allow | 43 | 2 | 1 | Yes | No |
| 17025948 | PRESSURE ACTUATED FLOW CONTROL DEVICE FOR GRAVITY IV SETS | September 2020 | July 2023 | Allow | 34 | 2 | 1 | No | No |
| 17019619 | THERAPEUTIC SUBSTANCE DELIVERY | September 2020 | September 2023 | Allow | 36 | 2 | 0 | Yes | No |
| 17013187 | INDWELLING INTRAVASCULAR APHAERETIC SYSTEM FOR IN VIVO ENRICHMENT OF CIRCULATING TUMOR CELLS | September 2020 | April 2024 | Allow | 44 | 3 | 0 | Yes | No |
| 16997803 | ATRAUMATIC SUBCUTANEOUS MEDICATION DELIVERY | August 2020 | March 2024 | Allow | 43 | 2 | 0 | No | No |
| 16996083 | ANGIOGRAM INJECTIONS USING ELECTROCARDIOGRAPHIC SYNCHRONIZATION | August 2020 | March 2023 | Allow | 31 | 1 | 1 | Yes | No |
| 16986129 | SYRINGE | August 2020 | October 2023 | Allow | 38 | 2 | 1 | Yes | No |
| 16940465 | METHODS OF PREPARING BALLOON EXPANDABLE CATHETERS FOR CARDIAC AND VASCULAR INTERVENTIONS | July 2020 | September 2023 | Allow | 38 | 2 | 0 | No | No |
| 16931997 | FLUID INJECTION SYSTEM WITH ILLUMINATED FLUID RESERVOIR | July 2020 | January 2024 | Allow | 42 | 2 | 0 | No | No |
| 16922722 | Dual-Pump System for Delivering Embolic Beads or Other Therapeutic Substances into an Artery | July 2020 | July 2023 | Allow | 36 | 1 | 0 | No | No |
| 15733222 | INFUSION PUMP SYSTEMS AND METHODS FOR ADMINISTRATION SETS | June 2020 | October 2023 | Allow | 40 | 2 | 0 | Yes | No |
| 16892625 | COMPACT AUTO-INJECTOR | June 2020 | February 2024 | Allow | 44 | 2 | 0 | Yes | No |
| 16769041 | CHEMICAL LIQUID INJECTOR | June 2020 | July 2023 | Allow | 37 | 1 | 0 | Yes | No |
| 16877363 | STEERABLE GUIDING SHEATH WITH RACK AND PINION DEFLECTION MECHANISM | May 2020 | December 2023 | Allow | 43 | 2 | 0 | No | No |
| 16874904 | STEERABLE MEDICAL DEVICE AND METHOD | May 2020 | April 2023 | Allow | 35 | 1 | 0 | Yes | No |
| 16763757 | DRUG DELIVERY APPARATUS | May 2020 | April 2023 | Allow | 35 | 1 | 0 | Yes | No |
| 16871704 | ADJUSTABLE MEDIUM DIVERTER | May 2020 | December 2022 | Allow | 31 | 2 | 0 | Yes | No |
| 16870603 | Intravascular Treatment Site Access | May 2020 | March 2024 | Allow | 46 | 3 | 0 | Yes | No |
| 16760877 | SKIN CARE DEVICE | April 2020 | March 2023 | Allow | 35 | 2 | 0 | Yes | No |
| 16759435 | ASSISTANCE SYSTEM, ASSISTANCE METHOD, ASSISTANCE PROGRAM, AND RECORDING MEDIUM HAVING ASSISTANCE PROGRAM RECORDED THEREON | April 2020 | May 2021 | Allow | 13 | 2 | 0 | No | No |
| 16843895 | PORTABLE MEDICAL SPRAY | April 2020 | June 2023 | Abandon | 38 | 1 | 0 | No | No |
| 16753838 | INJECTOR DEVICE | April 2020 | June 2022 | Allow | 26 | 2 | 1 | Yes | No |
| 16838575 | BALLOON CATHETER WITH FORTIFIED PROXIMAL INFUSION OUTLET PORT, AND MANUFACTURING THEREOF | April 2020 | April 2024 | Abandon | 48 | 2 | 0 | No | No |
| 16652161 | Trigger Arrangement for an Infusion Device | March 2020 | November 2022 | Allow | 31 | 2 | 0 | Yes | No |
| 16651605 | ENERGY SELF-SUFFICIENT REAL TIME BIO-SIGNAL MONITORING AND NUTRIENT DELIVERY SYSTEM BASED ON SALINITY GRADIENT POWER GENERATION | March 2020 | February 2023 | Allow | 35 | 2 | 0 | Yes | No |
| 16832436 | ELUTION PROTOCOLS AND DOSAGES FOR RADIOPHARMACEUTICAL ELUTION SYSTEM | March 2020 | July 2023 | Allow | 40 | 3 | 0 | Yes | No |
| 16649757 | TRANS MIDDLE EAR-INNER EAR FLUID FLOW IMPLEMENTATIONS | March 2020 | June 2023 | Allow | 39 | 2 | 1 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SHAH, NILAY J.
With a 28.6% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 21.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SHAH, NILAY J works in Art Unit 3783 and has examined 378 patent applications in our dataset. With an allowance rate of 79.6%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 36 months.
Examiner SHAH, NILAY J's allowance rate of 79.6% places them in the 41% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by SHAH, NILAY J receive 2.19 office actions before reaching final disposition. This places the examiner in the 74% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by SHAH, NILAY J is 36 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +45.9% benefit to allowance rate for applications examined by SHAH, NILAY J. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 28.6% of applications are subsequently allowed. This success rate is in the 43% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 38.5% of cases where such amendments are filed. This entry rate is in the 51% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 83.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 63% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 68.2% of appeals filed. This is in the 48% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 35.3% are granted (fully or in part). This grant rate is in the 30% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.7% of allowed cases (in the 69% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.